(Q59650507)

English

Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial

scientific article published on 20 July 2004

Statements

Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit